Get the Daily Brief
Latest Biotech News
Biotech Growth and Regulatory Issues in Vienna and Europe
Vienna's biotech sector grew to €22.7 billion in 2023, driven by advances in research, innovation, and workforce expansion, positioning the city as a burgeoning life sciences hub. Concurrently,...
AI and Digital Transformation in Rural Healthcare Settings
Microsoft is accelerating digital innovation in rural hospitals by addressing cybersecurity challenges and promoting AI adoption with discounted tools, training, and an innovation lab. The...
Apogee’s Eczema Drug Shows Midstage Success Amid Established Competitors
Apogee Therapeutics has announced promising midstage clinical trial results for APG777, its experimental long-acting antibody therapy targeting atopic dermatitis. The trial demonstrated that...
FDA Faces Talent Drain and Morale Crisis Under Commissioner Makary
The FDA is experiencing a significant loss of experienced personnel amid low morale and heightened political interference. Following a reduction of 19% of its workforce coinciding with the...
US-China Regulatory Tensions Threaten Cross-Border Drug Development
A regulatory chill is emerging as the FDA signals tighter controls on clinical trials that transfer Americans’ cells to China for genetic engineering before reinfusion. Provoked by biosecurity...
Columbia’s AI System Detects Hidden Sperm, Enables Pregnancy Breakthrough
Columbia University’s STAR (Sperm Tracking and Recovery) platform applied astrophysics-derived algorithms to identify sperm cells missed by conventional microscopy in samples deemed sterile....
Novartis’ Cosentyx Falls Short in Giant Cell Arteritis Phase 3 Trial
Novartis announced that its blockbuster drug Cosentyx failed to outperform placebo in a Phase 3 study targeting giant cell arteritis, an autoimmune blood vessel disorder. The antibody therapy was...
European Commission Fines Alchem for Decade-Long API Cartel Participation
The European Commission concluded its investigation into Alchem, fining the drugmaker for involvement in an anti-competitive cartel regarding active pharmaceutical ingredients (APIs) spanning over...
FGF13 Emerges as Protective Agent Against Age-Related Hearing Loss
Researchers have identified fibroblast growth factor 13 (FGF13) as a critical molecule in preserving neuronal integrity within the inner ear, potentially delaying or halting hearing decline linked...
Novel Epigenetic Biomarkers Enable Noninvasive Nasopharyngeal Cancer Detection
A pioneering diagnostic approach utilizing DNA methylation markers derived from bilateral nasal swabs offers a noninvasive, automated method to detect nasopharyngeal carcinoma (NPC) at early...
Molecular Markers Illuminate Radiosensitivity in Adult Glioma Therapy
New research identifying molecular biomarkers predictive of radiosensitivity in adult gliomas aims to refine radiotherapy strategies for these aggressive brain tumors. Given glioma’s notorious...
Microsoft’s Rural Hospital Initiative Boosts Cybersecurity and AI Innovation
Microsoft is expanding its commitment to rural healthcare by providing discounted cybersecurity tools, free digital training, and establishing an AI innovation lab accessible to over 700 rural...
FDA Faces Morale Crisis Amid Staff Exodus and Political Influence
The Food and Drug Administration (FDA) is struggling with a significant loss of experienced staff and declining morale, factors that threaten to undermine its regulatory effectiveness. Since April...
US-China Relations Hit Biotech as FDA Tightens Oversight on Chinese Drug Trials
Rising political tensions between the U.S. and China have prompted the FDA to implement stricter regulatory measures affecting Chinese-developed drug investments and clinical trials. The agency...
Roche-Backed Chugai Enters Longevity Drug Space with Pfizer Partnership
Chugai Pharmaceutical, part of the Roche group headquartered in Tokyo, has ventured into the aging disease drug development arena through a strategic collaboration with Pfizer-allied Gero. This...
AI Breakthrough in Fertility: Columbia System Finds Sperm Missed by Experts
Researchers at Columbia University have developed an AI system named STAR, adapted from astrophysics algorithms, capable of detecting viable sperm cells overlooked by human embryologists. The...
Novartis Cosentyx Fails Phase 3 Trial for Rare Blood Vessel Disease
Novartis's antibody drug Cosentyx did not achieve its primary endpoint in a Phase 3 clinical trial for treating giant cell arteritis, a rare autoimmune disorder affecting blood vessels. The...
Microsoft Drives Digital Innovation to Bolster Rural Hospital Security
Microsoft is addressing growing cybersecurity and digital infrastructure challenges in rural hospitals through initiatives providing discounted technology, free training, and an AI innovation lab....
European Commission Fines Alchem Over Decade-Long API Price Fixing
The European Commission has penalized pharmaceutical firm Alchem, concluding its involvement in a cartel manipulating active pharmaceutical ingredient (API) prices for over ten years. This closure...
Emerging Research Links FGF13 to Prevention of Age-Related Hearing Loss
A new study identifies fibroblast growth factor 13 (FGF13) as a critical protector of neurons in the inner ear, offering potential therapeutic angles for combating age-associated hearing decline....